Welcome to the October 10 edition of Pathways’ Picks, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: the Trump administration tries to add legal clarity for value-based contracts, the first notified body is designated for the EU IVD Regulation, updates from China and India agencies, dates to remember, and more.
Medtech firms were hoping for more legal assurances to support setting up value-based, risk-sharing contracts with hospitals and others in two proposed rules dropped by the Trump administration October 9. It is not clear that they have gotten it yet. That news leads our Pathways’ Picks—a rundown of medtech policy items and key dates that should be on your radar this week.